Sobotka Glenn
Known title: Chief Accounting OfficerCIK: 0001855927
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Agilon Health Stock Moves Amid Peer Comparison. Recent market activity for Agilon Health has drawn attention to how its performance compares with other medical sector stocks this year. The company's stock is currently trading near a significant support level, which may be influencing investor sentiment. Analysts maintain a wide range of price targets, reflecting varying views on the company's future trajectory.
Transaction History
| ASTH | ▼ Sell | Other | 11,793 | $0 | 8/7/2026 | View on chart |
| ASTH | ▼ Sell | Tax Withholding | 662 | $16K | 3/26/2026 | View on chart |
| ASTH | ▲ Buy | Grant | 8,269 | $0 | 3/26/2025 | View on chart |
| ASTH | ▲ Buy | Grant | 6,432 | $0 | 3/26/2025 | View on chart |
| AGL | ▲ Buy | Grant | 2,439 | $0 | 4/14/2022 | View on chart |
| AGL | ▲ Buy | Option Exercise | 150,000 | $1.1M | 11/4/2021 | View on chart |
| AGL | ▼ Sell | Open Market | 150,000 | $3.8M | 11/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Astrana Health Forms Multi-State Partnership With Verda Healthcare
Astrana Health announced a multi-state partnership with Verda Healthcare to expand culturally tailored care in underserved U.S. communities. This move aims to broaden the company's reach, though some market observers note the stock may already reflect the value of this new agreement. The company also scheduled its Q3 2026 financial results release, keeping investors focused on upcoming performance metrics.
Astrana Health Forms Multi-State Partnership With Verda Healthcare. Astrana Health announced a multi-state partnership with Verda Healthcare to expand culturally tailored care in underserved U.S. communities. This move aims to broaden the company's reach, though some market observers note the stock may already reflect the value of this new agreement. The company also scheduled its Q3 2026 financial results release, keeping investors focused on upcoming performance metrics.